Ocata Therapeutics (OCAT) Reports Q3 Loss Per Share of $0.09
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/10/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
Tweet
Share
E-mailGet Alerts OCAT Hot Sheet
Join SI Premium – FREE
Ocata Therapeutics (NASDAQ: OCAT) reported Q3 EPS of ($0.09), versus ($0.13) reported last year.
For earnings history and earnings-related data on Ocata Therapeutics (OCAT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Top AI Semiconductor Stocks According to Stifel Analysis
- vVardis files for US IPO showing net loss, revenue growth
- Jet fuel prices near $5 per gallon in New York and Los Angeles
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
